Hepatitis C Information Central

Subclinical Hepatic Encephalopathy Impairs Daily Functioning

1. Butterworth RF. Pathogenesis and treatment of portal-systemic encephalopathy: an update. Dig Dis Sci 1992; 37: 321-327[Medline].

2. Parsons-Smith BG, Summerskill WHJ, Dawson AM, Sherlock S. The electroencephalograph in liver disease. Lancet 1957; 2: 867-871.

3. Gitlin N. Subclinical portal-systemic encephalopathy. Am J Gastroenterol 1988; 82: 8-11.

4. Zeegen R, Drinkwater JE, Dawson AM. Method for measuring cerebral dysfunction in patients with liver disease. Br Med J 1970; 2: 633-636[Medline].

5. Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978; 75: 462-469[Medline].

6. Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier RO, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980; 140: 519-521[Medline].

7. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy ambulant, non-shunted patients with cirrhosis. J Hepatol 1986; 3: 75-82[Medline].

8. Sood GK, Sarin SK, Mahaptra J, Broor SL. Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach. Am J Gastroenterol 1989; 2: 156-159.

9. Schomerus H, Schreiegg J. Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice. Z Gastroenterol 1993; 31: 231-234[Medline].

10. Tarter RE, Hegedus AM, van Thiel DH, Schade RR, Gavaler JS, Starzl TE. Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 1984; 86: 1421-1427[Abstract].

11. Rehnstrom S, Simert G, Hansson J, Johnson G, Vang J. Chronic hepatic encephalopathy. A psychometrical study. Scand J Gastroenterol 1977; 12: 305-311[Medline].

12. Moore JW, Dunk AA, Crawford JR, Deans H, Besson JAO, De Lacey G, Sinclair TS, et al. Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis. J Hepatol 1989; 9: 319-325[Medline].

13. Koch H, Schauder P, Schäfer G, Dahme B, Ebel W, Vahldiek B, König F, Henning H. 14. Untersuchungen zur diagnose und prävalenz der latenten hepatischen encep halopathie. Z Gastroenterol 1990; 28: 610-615[Medline].

15. Weissenborn K, Scholz M, Hinrichs H, Wiltfang J, Schmidt FW, Künkel H. Neurophysiological assessment of early hepatic encephalopathy. Electroenceph Clin Neurophysiol 1990; 75: 289-295[Medline].

16. Quero JC, Hartmann IJC, Meulstee J, Hop WCJ, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. HEPATOLOGY 1996; 24: 556-560[Abstract].

17. Yen CL, Liaw YF. Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy. Hepatogastroenterology 1990; 37: 332-334[Medline].

18. Quero JC, Schalm SW. Subclinical hepatic encephalopathy. Semin Liver Dis 1996; 16: 321-328[Medline].

19. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Döll W. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981; 26: 622-630[Medline].

20. McClain CJ, Potter TJ, Kromhout JP, Zieve L. The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy. J Clin Gastroenterol 1984; 6: 325-329[Medline].

21. Morgan MY, Alonso M, Stanger LC. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. J Hepatol 1989; 8: 208-217[Medline].

22. Egberts EH, Schomerus H, Hamster W, Jurgens P. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study. Gastroenterology 1985; 88: 887-895[Abstract].

23. Srivastava A, Mehta R, Rothke SP, Rademaker AW, Blei AT. Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance. J Hepatol 1994; 21: 1023-1028[Medline].

24. Kazis LE. Health outcome assessments in medicine: history, applications and new directions. Adv Intern Med 1991; 36: 109-130[Medline].

25. Bergner M, Bobbitt RA, Cartner WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care 1981; 19: 787-805[Medline].

26. Sullivan M. The Sickness Impact Profile (SIP): an instrument for overall health assessment; a basic evaluation. JDR 1988; 13: 167-169.

27. Tarter RE, Switala J, Arria A, Van Thiel DH. Impact of liver disease on daily living in transplantation candidates. J Clin Epidemiol 1991; 44: 1079-1083[Medline].

28. Tarter RE, Switala J, Arria A, Plail J, Van Thiel DH. Quality of life before and after orthotopic hepatic transplantation. Arch Intern Med 1991; 151: 1521-1526[Medline].

29. Tarter RE, Switala J, Plail J, Havrilla J, Van Thiel DH. Severity of hepatic encephalopathy before liver transplantation is associated with quality of life after transplantation. Arch Intern Med 1992; 152: 2097-2101[Medline].

30. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, et al. Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Therapeut 1994; 16: 334-343[Medline].

31. Rijt CCD van der. Hepatic encephalopathy: clinical and experimental studies [Thesis]. Rotterdam, 1991.

32. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649[Medline].

33. Reitan RM. Validity of the trail making test as an indication of organic brain damage. Percept Mot Skills 1958; 8: 271-276.

34. Schönleber R. Standardisierung eines psychometrischen Tests zur Erfassung der hepatischen encephalopathie [Thesis]. Tübingen 1989.

35. Lezak MD. A compendium of tests and assessment techniques. In: Lezak MD, ed. Neuropsychological Assessment. New York: Oxford University Press , 1995.

36. Stinissen J, Willems PJ, Coetsier P, Hulsman WLL. Handleiding bij de Neder landstalige bewerking van de Wechsler Adult Intelligence Scale. Lisse, the Netherlands: Swets & Zeitlinger B.V. , 1970 [ISBN 90 265 0208087].

37. Jasper HH. The ten twenty electrode system of the international federation. Electroenceph Clin Neurophysiol 1958; 10: 371-375.

38. Van Der Rijt CCD, Schalm SW, De Groot GH, De Vlieger M. Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroenceph Clin Neurophysiol 1984; 57: 423-426[Medline].

39. De Melker RA, Touw-Otten F, Jacobs HM, Luttik A. De waarde van de "Sickness Impact Profile" als uitkomstmeting. Ned Tijdschr Geneeskd 1990; 134: 946-948[Medline].

40. Jacobs HM, Luttik A, Touw-Otten FWMM, De Melker RA. De "Sickness Impact Profile": resultaten van een valideringsonderzoek van de Nederlandse versie. Ned Tijdschr Geneeskd 1990; 134: 1950-1952[Medline].

41. Streiner DL, Norman GR. Health Measurement Scales. Oxford: Oxford Medical Publications 1989 [ISBN 0 19 2617737].

42. Bravo G, Potvin L. Estimating the reliability of continuous measures with cron bach's alpha and intraclass correlation coefficient: toward the integration of two traditions. J Clin Epidemiol 1991; 44: 381-390[Medline].

43. Nunnaly JC. Psychometric Theory. New York: McGraw Hill , 1978.

44. Essink-Bot ML, Krabbe PFM, Agt HME van, Bonsel GJ. NHP or SIP? A comparative study in renal insufficiency associated anemia. Qual Life Res 1996; 5: 91-100[Medline].

45. Conn HO. The hepatic encephalopathies. In: Conn HO, Bircher J, eds. Hepatic Encephalopathy: Syndromes and Therapies. Bloomington: Medi-Ed press, 1994:1-12.

Return To Article

table Of Contents